F7 rs121964935: Understanding Factor VII Deficiency Variants
The rs121964935 variant is a specific genetic change located within the F7 gene, which provides instructions for making coagulation factor VII. This variant is associated with factor VII deficiency, a rare inherited condition that can affect the blood's ability to clot properly.
What each genotype means
Typical coagulation factor activity
This genotype represents the most common form of the F7 gene, which provides instructions for producing coagulation factor VII. Individuals with this profile typically maintain standard levels of factor VII activity required for normal blood clotting processes. This is considered the baseline state in the general population.
This is the most common genotype found across all global populations.
Potential reduced factor activity
Carrying one copy of this variant may be associated with variations in factor VII plasma levels, though it does not typically cause clinical bleeding disorders on its own. Because factor VII deficiency is an autosomal recessive condition, individuals with one copy are generally asymptomatic. Please discuss any concerns regarding coagulation or surgical planning with your healthcare provider.
This genotype is rare, occurring at low frequencies in most populations.
Increased risk of deficiency
This genotype is associated with a higher likelihood of reduced coagulation factor VII activity, which is the underlying cause of hereditary factor VII deficiency. While clinical symptoms are highly variable and do not always correlate with factor levels, this profile warrants clinical monitoring, especially before surgeries or after injuries. Please consult with a hematologist or your primary care physician to discuss your specific health context.
This genotype is very rare and is primarily identified in clinical settings among individuals being evaluated for bleeding disorders.
What is the rs121964935 Variant?
The rs121964935 variant is a specific alteration in the DNA sequence of the F7 gene. In genetics, an rsID (reference SNP cluster ID) like rs121964935 acts as a unique identifier for a specific location in the human genome. This variant is categorized as a health-related genetic marker because it is linked to the production of coagulation factor VII, a protein essential for the blood clotting cascade. When a variant occurs in this gene, it may lead to a reduction in the amount or the functional activity of the factor VII protein in the bloodstream. Because the F7 gene is located on chromosome 13, individuals inherit two copies of this gene—one from each parent. The presence of this variant at this specific site is studied by researchers to understand how it contributes to the molecular mechanisms of rare bleeding disorders.
The Role of the F7 Gene
The F7 gene encodes coagulation factor VII, a vitamin K-dependent glycoprotein that plays a critical role in the extrinsic pathway of blood coagulation. When an injury occurs, factor VII binds to tissue factor, initiating a series of chemical reactions that lead to the formation of a blood clot. This process is vital for stopping bleeding after an injury or surgery. Mutations or variants within the F7 gene can disrupt this process by affecting the protein's expression, its secretion from cells, or its ability to bind to tissue factor. Because factor VII is the primary initiator of the clotting cascade, even minor reductions in its activity can have significant clinical implications. Research into the F7 gene is extensive, with nearly 300 different mutations identified that can lead to varying degrees of factor VII deficiency, ranging from mild to severe.
Research and Clinical Associations
Scientific research has established a clear link between variants in the F7 gene and factor VII deficiency, a rare autosomal recessive bleeding disorder. Evidence for these associations is considered moderate to strong in clinical genetics, as researchers have documented numerous cases where specific F7 variants correlate with reduced factor VII coagulant activity (FVII:C). However, a notable finding in the literature is that the severity of a patient's genotype does not always perfectly predict their clinical symptoms. Some individuals with significantly reduced factor VII levels may experience few or no bleeding problems, while others may face more frequent episodes. This variability suggests that other genetic and environmental factors also influence how the body manages clotting. Clinicians often use laboratory tests, such as prothrombin time (PT) and specific factor activity assays, to assess the impact of these variants on an individual's health.
Population Frequency and Interpretation
The rs121964935 variant is classified as rare in the general population. Because factor VII deficiency is an autosomal recessive condition, it typically requires an individual to inherit two copies of a pathogenic variant—or a combination of different variants—to manifest the clinical disorder. In many populations, the frequency of such specific rare variants is extremely low, often making them difficult to study without large-scale genomic databases. It is important to note that having a rare variant does not automatically mean an individual will have a bleeding disorder. Genetic testing results should always be interpreted by a qualified medical professional or genetic counselor who can place the findings in the context of an individual's personal and family medical history. This information is intended for educational purposes and should not be used to diagnose or treat any medical condition.
Managing Genetic Information
If you have received information about an F7 variant, it is essential to understand that genetic data is only one piece of a larger health puzzle. You cannot use this information to self-diagnose or determine your risk of bleeding without professional clinical evaluation. If you are concerned about your clotting ability or have a family history of bleeding disorders, consult with a hematologist or a primary care physician. They can order appropriate blood tests to measure your actual factor VII activity levels and provide guidance based on your specific clinical needs. Never make changes to your medications or surgical plans based on genetic reports without first discussing them with your healthcare provider. Your clinician can help you understand whether your genetic profile requires any specific monitoring or precautions, especially before undergoing invasive procedures or surgeries.
How common is this variant?
The rs121964935 variant is considered rare across global populations, with its specific frequency varying significantly depending on ancestral background.
Frequently asked questions
What is factor VII deficiency?
Factor VII deficiency is a rare inherited bleeding disorder caused by mutations in the F7 gene. It prevents the blood from clotting normally, which can lead to symptoms like nosebleeds, easy bruising, or prolonged bleeding after surgery.
Is rs121964935 dangerous?
The danger associated with a genetic variant depends on whether it is inherited in a way that causes a deficiency. You should discuss your specific genetic results with a doctor to understand if they have any clinical significance for your health.
Can I be a carrier of an F7 variant?
Yes, it is possible to be a carrier if you have the variant on only one of your two F7 gene copies. Carriers typically do not experience symptoms of factor VII deficiency but may pass the variant to their children.
How is factor VII deficiency diagnosed?
Diagnosis is typically made through blood tests that measure prothrombin time (PT) and the specific activity level of factor VII. Genetic testing may be used to confirm the presence of specific variants in the F7 gene.
Sources & further reading
Educational information only, last refreshed 10/1/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121964935?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29